Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody.

Haack H, Johnson LA, Fry CJ, Crosby K, Polakiewicz RD, Stelow EB, Hong SM, Schwartz BE, Cameron MJ, Rubin MA, Chang MC, Aster JC, French CA.

Am J Surg Pathol. 2009 Jul;33(7):984-91. doi: 10.1097/PAS.0b013e318198d666.

2.

[Utility of NUT gene expression and rearrangement in diagnosis of NUT midline carcinoma in upper respiratory tract].

Fang W, French CA, Cameron MJ, Han YD, Liu HG.

Zhonghua Bing Li Xue Za Zhi. 2012 Aug;41(8):519-24. doi: 10.3760/cma.j.issn.0529-5807.2012.08.003. Chinese.

PMID:
23157742
3.

Demystified molecular pathology of NUT midline carcinomas.

French CA.

J Clin Pathol. 2010 Jun;63(6):492-6. doi: 10.1136/jcp.2007.052902. Epub 2008 Jun 13. Review.

PMID:
18552174
4.

NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract.

Stelow EB, Bellizzi AM, Taneja K, Mills SE, Legallo RD, Kutok JL, Aster JC, French CA.

Am J Surg Pathol. 2008 Jun;32(6):828-34. doi: 10.1097/PAS.0b013e31815a3900.

PMID:
18391746
5.

Clinicopathological significance of NUT rearrangements in poorly differentiated malignant tumors of the upper respiratory tract.

Fang W, French CA, Cameron MJ, Han Y, Liu H.

Int J Surg Pathol. 2013 Apr;21(2):102-10. doi: 10.1177/1066896912451651. Epub 2012 Jul 9.

PMID:
22777717
6.

NUT midline carcinoma.

French CA.

Cancer Genet Cytogenet. 2010 Nov;203(1):16-20. doi: 10.1016/j.cancergencyto.2010.06.007. Review.

7.

A rare Japanese case with a NUT midline carcinoma in the nasal cavity: a case report with immunohistochemical and genetic analyses.

Suzuki S, Kurabe N, Minato H, Ohkubo A, Ohnishi I, Tanioka F, Sugimura H.

Pathol Res Pract. 2014 Jun;210(6):383-8. doi: 10.1016/j.prp.2014.01.013. Epub 2014 Feb 22.

PMID:
24655834
8.

NSD3-NUT-expressing midline carcinoma of the lung: first characterization of primary cancer tissue.

Suzuki S, Kurabe N, Ohnishi I, Yasuda K, Aoshima Y, Naito M, Tanioka F, Sugimura H.

Pathol Res Pract. 2015 May;211(5):404-8. doi: 10.1016/j.prp.2014.10.013. Epub 2014 Nov 13.

PMID:
25466466
9.

NUT midline carcinoma of the larynx: an international series and review of the literature.

Hellquist H, French CA, Bishop JA, Coca-Pelaz A, Propst EJ, Paiva Correia A, Ngan BY, Grant R, Cipriani NA, Vokes D, Henrique R, Pardal F, Vizcaino JR, Rinaldo A, Ferlito A.

Histopathology. 2017 May;70(6):861-868. doi: 10.1111/his.13143. Epub 2017 Feb 21. Review.

PMID:
27926786
10.

Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma.

Lee JK, Louzada S, An Y, Kim SY, Kim S, Youk J, Park S, Koo SH, Keam B, Jeon YK, Ku JL, Yang F, Kim TM, Ju YS.

Ann Oncol. 2017 Apr 1;28(4):890-897. doi: 10.1093/annonc/mdw686.

11.

NUT midline carcinoma presenting with bilateral ovarian metastases: a case report.

Dragoescu E, French C, Cassano A, Baker S Jr, Chafe W.

Int J Gynecol Pathol. 2015 Mar;34(2):136-42. doi: 10.1097/PGP.0000000000000129.

PMID:
25675182
12.

Pathologic characteristics of NUT midline carcinoma arising in the mediastinum.

Evans AG, French CA, Cameron MJ, Fletcher CD, Jackman DM, Lathan CS, Sholl LM.

Am J Surg Pathol. 2012 Aug;36(8):1222-7. doi: 10.1097/PAS.0b013e318258f03b.

13.

New developments in the molecular pathogenesis of head and neck tumors: a review of tumor-specific fusion oncogenes in mucoepidermoid carcinoma, adenoid cystic carcinoma, and NUT midline carcinoma.

Bhaijee F, Pepper DJ, Pitman KT, Bell D.

Ann Diagn Pathol. 2011 Feb;15(1):69-77. doi: 10.1016/j.anndiagpath.2010.12.001. Review.

PMID:
21238915
14.

Cytopathologic features of NUT midline carcinoma: A series of 26 specimens from 13 patients.

Bishop JA, French CA, Ali SZ.

Cancer. 2016 Dec;124(12):901-908. doi: 10.1002/cncy.21761. Epub 2016 Jul 11.

15.

NUT midline carcinomas of the sinonasal tract.

Bishop JA, Westra WH.

Am J Surg Pathol. 2012 Aug;36(8):1216-21. doi: 10.1097/PAS.0b013e318254ce54.

16.

Nuclear protein in testis midline carcinomas: a lethal and underrecognized entity.

Davis BN, Karabakhtsian RG, Pettigrew AL, Arnold SM, French CA, Brill YM.

Arch Pathol Lab Med. 2011 Nov;135(11):1494-8. doi: 10.5858/arpa.2010-0389-CR.

PMID:
22032580
17.

NUT midline carcinoma of the parotid gland with mesenchymal differentiation.

den Bakker MA, Beverloo BH, van den Heuvel-Eibrink MM, Meeuwis CA, Tan LM, Johnson LA, French CA, van Leenders GJ.

Am J Surg Pathol. 2009 Aug;33(8):1253-8. doi: 10.1097/PAS.0b013e3181abe120.

PMID:
19561446
18.

Nuclear protein in testis midline carcinoma with unusual elevation of α-fetoprotein and synaptophysin positivity: a case report and review of the literature.

Raza A, Cao H, Conrad R, Cobb C, Castelino-Prabhu S, Mirshahidi S, Shiraz P, Mirshahidi HR.

Expert Rev Anticancer Ther. 2015;15(10):1199-213. doi: 10.1586/14737140.2015.1082909. Epub 2015 Sep 1. Review.

PMID:
26402248
19.

The importance of diagnosing NUT midline carcinoma.

French CA.

Head Neck Pathol. 2013 Mar;7(1):11-6. doi: 10.1007/s12105-013-0428-1. Epub 2013 Mar 5. Review.

20.

Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma.

Thompson-Wicking K, Francis RW, Stirnweiss A, Ferrari E, Welch MD, Baker E, Murch AR, Gout AM, Carter KW, Charles AK, Phillips MB, Kees UR, Beesley AH.

Oncogene. 2013 Sep 26;32(39):4664-74. doi: 10.1038/onc.2012.487. Epub 2012 Nov 5.

PMID:
23128391

Supplemental Content

Support Center